310 results on '"Choe, Hyeryun"'
Search Results
2. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
3. An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
4. Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates
5. Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice
6. Mechanisms of SARS-CoV-2 entry into cells
7. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening
8. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
9. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
10. Transferrin receptor 1 is a cellular receptor for human heme-albumin
11. Structural Basis of Tyrosine Sulfation and V H - gene Usage in Antibodies That Recognize the HIV Type 1 Coreceptor-Binding Site on gp120
12. Potent Neutralization of Severe Acute Respiratory Syndrome (SARS) Coronavirus by a Human mAb to S1 Protein That Blocks Receptor Association
13. AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses
14. BACE2, a β -Secretase Homolog, Cleaves at the β Site and within the amyloid-β Region of the amyloid-β Precursor Protein
15. CD4-Independent Binding of SIV gp 120 to Rhesus CCR5
16. Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions
17. Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses
18. Heavy-chain CDR3-engineered B cells facilitatein vivoevaluation of HIV-1 vaccine candidates
19. An IgM-like Inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2
20. SARS-CoV, But not HCoV-NL63, Utilizes Cathepsins to Infect Cells: Viral Entry
21. Insights from the Association of SARS-CoV S-Protein with its Receptor, ACE2
22. The SARS Coronavirus receptor ACE 2 A potential target for antiviral therapy
23. SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells*
24. Protein Evolution with an Expanded Genetic Code
25. Receptor Determinants of Zoonotic Transmission of New World Hemorrhagic Fever Arenaviruses
26. Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein
27. Mechanisms of SARS-CoV-2 entry into cells
28. Angiotensin-Converting Enzyme 2, the Cellular Receptor for Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
29. An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines
30. How SARS-CoV-2 first adapted in humans
31. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
32. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses
33. Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
34. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein
35. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses
36. Phosphatidylethanolamine and Phosphatidylserine Synergize To Enhance GAS6/AXL-Mediated Virus Infection and Efferocytosis
37. AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery
38. An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines
39. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
40. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
41. Structural basis of tyrosine sulfation and [V.sub.H]-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
42. Chapter 7 Tyrosine Sulfation of HIV‐1 Coreceptors and Other Chemokine Receptors
43. Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
44. Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
45. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity
46. The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
47. Chemokine receptors in HIV-1 and SIV infection
48. Reply to Marques and Drexler, “Complex Scenario of Homotypic and Heterotypic Zika Virus Immune Enhancement”
49. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking
50. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.